ArticleBMC psychology2025
Anxiety, depressive and insomnia symptoms among patients with depression: a network perspective.
Article in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mapping the central symptom structure of the insomnia severity index (ISI-7) and sleep duration: a network analysis.Sleep & breathing = Schlaf & Atmung · 2026Article
- The relationship between school belonging and depressive symptoms among Chinese college students: a moderated mediation model.Frontiers in psychology · 2026Article
- Sex hormones and functional gastrointestinal disorders in menopausal women.Frontiers in endocrinology · 2026Review
- Network characteristics of the youth's insomnia and emotional symptoms and their gender differences.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe aim of this study was to utilize network analysis to explore the interconnections among anxiety, depressive, and insomnia symptoms in depressed patients in China.
methodsThe study included two surveys, the baseline survey was conducted from May 18, 2020 to June 18, 2020, and the follow-up survey was conducted 5 months later. A total of 4476 patients completed the baseline survey, and 1877 of them completed the follow-up survey. Depression symptoms were evaluated using the 9-item Patient Health Questionnaire-9 (PHQ-9), anxiety symptoms were evaluated using the 7-item Generalized Anxiety Disorder (GAD-7), and insomnia symptoms were evaluated using the 7-item Insomnia Severity Index (ISI). The centrality indices are utilized in the network analysis, and using Network Comparison Test (NCT) to evaluate the differences between the network structures at two different time points.
resultsNetwork analysis revealed that the central symptom value was ISI5 ("Interfere with your daily functioning") in the baseline networks and ISI4 ("Worried/distressed") in the follow-up networks, the symptom with the bridge symptom value in both networks was PHQ9-3 ("Sleep"). The NCT results revealed no significant differences in edge weights and global strength among participants who completed both baseline and follow-up surveys.
conclusionsOur results suggest that central symptom (e.g., "Interfere with your daily functioning","Worried/distressed") and bridge symptom PHQ9-3 ("Sleep") can be prioritized as a target for intervention and treatment in patients with depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.